Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $59.82 million. The enterprise value is $56.24 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TELO has 29.76 million shares outstanding. The number of shares has increased by 9.14% in one year.
Current Share Class | 29.76M |
Shares Outstanding | 29.76M |
Shares Change (YoY) | +9.14% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | 17.89% |
Owned by Institutions (%) | 12.50% |
Float | 17.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 36.96 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75
Current Ratio | 0.75 |
Quick Ratio | 0.62 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -872.57% and return on invested capital (ROIC) is -529.03%.
Return on Equity (ROE) | -872.57% |
Return on Assets (ROA) | -391.62% |
Return on Invested Capital (ROIC) | -529.03% |
Return on Capital Employed (ROCE) | 7,767.49% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.38M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.59% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -62.59% |
50-Day Moving Average | 2.64 |
200-Day Moving Average | 4.28 |
Relative Strength Index (RSI) | 40.24 |
Average Volume (20 Days) | 146,422 |
Short Selling Information
The latest short interest is 2.17 million, so 7.30% of the outstanding shares have been sold short.
Short Interest | 2.17M |
Short Previous Month | 2.23M |
Short % of Shares Out | 7.30% |
Short % of Float | 12.34% |
Short Ratio (days to cover) | 15.43 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -12.51M |
Pretax Income | n/a |
Net Income | -12.46M |
EBITDA | n/a |
EBIT | -12.51M |
Earnings Per Share (EPS) | -$0.41 |
Full Income Statement Balance Sheet
The company has $402,999 in cash and $93,432 in debt, giving a net cash position of $309,567 or $0.01 per share.
Cash & Cash Equivalents | 402,999 |
Total Debt | 93,432 |
Net Cash | 309,567 |
Net Cash Per Share | $0.01 |
Equity (Book Value) | -161,106 |
Book Value Per Share | -0.01 |
Working Capital | -161,106 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -3.99M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |